Animal Health Discovery Services

Avista Pharma offers comprehensive animal health drug discovery services.  Our state-of-the-art parasiticide platform supports the discovery and development of products for companion and production animals.  The Avista bio-profiling portfolio includes over 30 species of clinically and commercially important ectoparasites (fleas, ticks, flies, mosquitos) and endoparasites (intestinal worms, heartworms), as well as protozoans (leishmania, cryptosporidium, trypanosomes). Avista has a proven record of success in the identification and optimization of anti-parasitics, with several candidates progressing into clinical studies and commercialization.